ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 3)

Sleep disturbances remain one of the most challenging aspects of attention-deficit/hyperactivity disorder (ADHD) management across all age groups, and stimulants, while effective for core symptoms, often exacerbate these issues. This article explores age-specific approaches to improving sleep in patients with ADHD, from preschoolers to adults. It outlines the limitations of pharmacologic therapy in younger children, emphasizes the value of behavioral interventions, and examines the role of non-stimulant medications such as guanfacine, atomoxetine, clonidine, and viloxazine in school-aged patients and adolescents. In adults, the article reviews promising—but underexplored—strategies including bright light therapy, weighted blankets, and targeted behavioral modifications.

Stimulants remain the first-line treatment of ADHD for most children, adolescents, and adults,¹ and sleep disturbances are among the most frequently reported side effects of these agents.^2,3 Adverse effects of stimulants include difficulty falling asleep, nighttime wakings, sleep resistance, difficulty waking, daytime sleepiness, nightmares, sleepwalking, and restless legs syndrome.⁴ While other adverse effects such as decreased appetite, irritability, and mild cardiovascular changes are also reported,³ they are often considered less disruptive than sleep-related concerns in many patients.² 

Treatment of Sleep Disturbances in Preschoolers With ADHD

Pharmacological treatment in preschool-aged children is less effective and more likely to cause adverse effects compared to older children.³ In fact, there are currently no pharmacologic options for sleep disturbances approved for preschoolers.⁴ In this age group, psychosocial and behavioral interventions should be the primary approach to treating ADHD.³ Consequently, non-pharmacological approaches are prioritized, although very few studies specifically examine them in preschool-aged children. 

Among these, parental behavior management training (PBMT) is frequently recommended as the preferred option for treating sleep disturbances in children aged 4 to 6 years with ADHD.⁴ In a study involving 35 preschool-aged children, both PBMT and PBMT combined with repetitive transcranial magnetic stimulation improved sleep parameters; however, the combined intervention was significantly more effective.⁴ In general, medication use in preschoolers should be approached more cautiously than in school-age children and reserved for very severe cases.³

Treatment of Sleep Disturbances in School-Aged Children and Adolescents

The decision to initiate pharmacological treatment for school-aged children and adolescents with ADHD primarily depends on the severity of symptoms, as highlighted in clinical guidelines; those with severe symptoms “should” receive medication, while those with low-to-moderate severity “can” be considered for it.³ Nonetheless, this decision should also incorporate individual factors such as the child's level of distress, family circumstances, coexisting conditions, and overall psychosocial functioning.³

For children and adolescents with ADHD and disturbed sleep, the non-stimulant alpha-2 agonists guanfacine and clonidine, or the selective norepinephrine receptor inhibitor (SNRI) atomoxetine, or the SNRI/5HT modulator viloxazine, may serve as effective alternatives.^3,5 These agents improve core ADHD symptoms without the dopaminergic activation seen with stimulants that can disrupt sleep.³ Non-stimulants act more gradually on norepinephrine, which helps prevent the late-day rebound hyperactivity that may further impair sleep. Switching to atomoxetine or viloxazine may benefit patients with ongoing sleep issues.⁵ Atomoxetine has shown very few effects on sleep parameters and can, in fact, improve sleep-related behavior, though somnolence is a common side effect.^6,7 Adjunctive evening administration of guanfacine or clonidine may promote sleep, though studies report mixed effects on sleep architecture and daytime drowsiness.^6,8 The extended duration of action of available non-stimulants may also allow for use of lower stimulant doses.³

Non-pharmacological interventions may also improve sleep in children with ADHD. Behavioral sleep strategies, including sleep hygiene education and standardized behavioral techniques, have outperformed standard care.² One distance-based behavioral program combining manual and telephone coaching significantly improved sleep habits.² Parent training interventions targeting bedtime resistance have proven effective, and educational programs incorporating a sleep hygiene session and take-home materials improved multiple sleep-related outcomes, including bedtime resistance, sleep duration, and daytime sleepiness.² Weighted blankets have also improved total sleep time, sleep efficiency, and nighttime awakenings.²

Sleep Disturbances in Adults With ADHD

A systematic review identified 6 studies on sleep interventions for adults with ADHD, including 3 on bright light therapy, one on behavioral treatment, one using weighted blankets, and one on the sleep medication, ramelteon.⁹ These studies had several methodologic limitations but offered some encouraging results. Only the largest bright light and weighted blanket studies used control conditions. Most studies confirmed ADHD diagnoses using Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria, though the behavioral and blanket studies included individuals with past ADHD diagnoses but no systematic confirmation. All studies reported improvements in sleep parameters. Two bright light therapy studies showed a measurable shift in melatonin onset, indicating circadian rhythm improvement. The behavioral study focused on improving sleep hygiene and managing light and stimulant timing. Only one controlled trial using a sleep medication was found; ramelteon demonstrated mixed results, improving sleep timing but worsening fragmentation and fatigue. A small chart review also suggested mirtazapine might help with stimulant-related insomnia in adults with ADHD, though evidence is limited.⁹ 

Conclusion

Sleep disturbances are common across all age groups of patients with ADHD, often caused or worsened by the stimulant medications used to treat core ADHD symptoms. Treatment approaches vary by age, but non-pharmacological strategies are generally favored in younger populations due to concerns about adverse events. In preschoolers, behavioral interventions such as parent training remain the first-line approach for both ADHD symptoms and sleep issues. Among school-aged children and adolescents, non-stimulant medications such as guanfacine, clonidine, atomoxetine, and viloxazine may help address both core ADHD symptoms and sleep concerns. Behavioral interventions—such as sleep hygiene education, establishing consistent bedtime routines, and the use of weighted blankets—have been shown to be effective. In adults, bright light therapy, behavioral treatments, and weighted blankets have also demonstrated benefits. Overall, individualized, age-appropriate treatment plans that prioritize sleep health can improve quality of life in people with ADHD.

References:

1. Faraone SV, Po MD, Komolova M, Cortese S. Sleep-associated adverse events during methylphenidate treatment of attention-deficit/ hyperactivity disorder: A meta-analysis. J Clin Psychiatry. 2019;80:18r12210. doi:10.4088/JCP.18r12210
2. Cortese S, Veronesi GF, Gabellone A, et al. The management of sleep disturbances in children with attention-deficit/hyperactivity disorder (ADHD): An update of the literature. Expert Rev Neurother. 2024;24(6):585-596. doi:10.1080/14737175.2024.2353692
3. Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther. 2022:230:107940. doi:10.1016/j.pharmthera.2021.107940
4. Yilin J, Heng Z, Fei Z, Jiayang L. Exploring the effects of repetitive transcranial magnetic stimulation on comorbid sleep disorders in preschool children with attention-deficit hyperactivity disorder. Psychiatry Clin Psychopharmacol. 2024;34(1):1-8. doi:10.5152/pcp.2024.23702
5. Cutler AJ, Mattingly GW, Jain R, O'Neal W. Current and future nonstimulants in the treatment of pediatric ADHD: Monoamine reuptake inhibitors, receptor modulators, and multimodal agents. CNS Spectr. 2022;27(2):199-207. doi:10.1017/S1092852920001984
6. Bondopadhyay U, Diaz-Orueta U, Coogan AN. A systematic review of sleep and circadian rhythms in children with attention deficit hyperactivity disorder. J Atten Disord. 2022;26:149–224. doi:10.1177/1087054720978556
7. Rocha NS, Correa RDESA, de Melo Dias AC, Bueno CDF. Association between sleep pattern and pharmacological treatment in children with attention deficit disorder with hyperactivity: A systematic review. Rev Paul Pediatr. 2023:41:e2022065. doi:10.1590/1984-0462/2023/41/2022065
8. Dey A, Do TL, Almagor D, Khullar A. Managing comorbid sleep issues in patients with attention-deficit/hyperactivity disorder. CMAJ. 2025;197(12):E323-E324. doi:10.1503/cmaj.241262
9. Surman CBH, Walsh DM. Managing sleep in adults with ADHD: From science to pragmatic approaches. Brain Sci. 2021;11(10):1361. Published 2021 Oct 16. doi:10.3390/brainsci11101361